Biogen GmbH
Industry / private company
Location:
München,
Germany (DE)
ROR: https://ror.org/014rfma52
A multicenter, prospective cohort study on the anti-SARS-CoV-2 vaccination response in patients with multiple sclerosis in Germany (2025)
Berthele A, Gödel C, Kallmann BA, Kowarik M, Lehmann-Horn K, Marziniak M, Rauer S, et al.
Journal article
Anti-SARS-CoV-2 vaccination immune response in MS patients: interim results of a multicentre, prospective cohort study (2022)
Berthele A, Goedel C, Kallmann B, Kowarik M, Lehmann-Horn K, Marziniak M, Meyer C, et al.
Conference contribution